Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload
Authors:
- 1 September 2000
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 36 (3) , 355-359
Abstract
—Cardiac natriuretic peptides, especially amino terminal pro–Brain Natriuretic Peptide (NT-proBNP), are emerging as powerful circulating markers of cardiac function. However, the in vivo secretion and elimination (t1/2) of these peptides during acute volume overload have not been studied. We present the first report of the secretion and elimination of cardiac natriuretic peptides, based on deconvolution analysis of endogenous ovine plasma levels measured by specific radioimmunoassay. Four normal, conscious sheep underwent rapid right ventricular pacing (225 bpm) for 1 hour to stimulate acute cardiac natriuretic peptide release. Plasma samples and right atrial pressure measurements were taken at regular intervals 30 minutes before, during, and 4 hours after pacing. Baseline right atrial pressure significantly increased (P=0.02) during the 1 hour of pacing in association with a prompt increase in plasma BNP (P=0.03), atrial natriuretic peptide (P=0.01), and NT-proBNP (P=0.02). Deconvolution analysis showed that the t1/2 of NT-proBNP (69.6±10.8 minutes) was 15-fold longer than BNP (4.8±1.0 minutes). Despite sustained increases in atrial pressure, cardiac secretion of natriuretic peptides (particularly atrial natriuretic peptide) fell during the pacing period, suggesting a finite source of peptide for secretion. Size-exclusion high-performance liquid chromatography revealed NT-proBNP to be a single immunoreactive peak, whereas BNP comprised at least 2 immunoreactive forms. These findings, especially the prompt secretion of BNP and the prolonged t1/2 of NT-proBNP, clarify the metabolism of BNP forms and help to explain the diagnostic value of NT-proBNP measurement as a sensitive marker of ventricular function.Keywords
This publication has 30 references indexed in Scilit:
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Differential Effects of Protein Kinase C, Ras, and Raf-1 Kinase on the Induction of the Cardiac B-type Natriuretic Peptide Gene through a Critical Promoter-proximal M-CAT ElementJournal of Biological Chemistry, 1997
- Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failureJACC, 1996
- Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.Journal of Clinical Investigation, 1995
- Biochemistry of natriuretic peptidesJournal of Internal Medicine, 1994
- A decade of atrial natriuretic factor researchCanadian Journal of Physiology and Pharmacology, 1991
- NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: Identification, radioimmunoassay and half-lifePeptides, 1988
- Physiological Role of Silent Receptors of Atrial Natriuretic FactorScience, 1987
- Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasmaBiochemical and Biophysical Research Communications, 1987
- Identification of a biologically active circulating form of rat atrial natriuretic factorBiochemical and Biophysical Research Communications, 1985